Successful Skeletal Aging: A Marker of Low Fracture Risk and Longevity. The Study of Osteoporotic Fractures (SOF)

Successful aging is multidimensional, and many phenotypes have been proposed. We examined a biomarker of aging based on repeated measures of BMD for up to 15 yr and hypothesized that maintenance of BMD will be associated with low fracture risk and disability and improved survival. We studied 9704 wo...

Full description

Saved in:
Bibliographic Details
Published inJournal of bone and mineral research Vol. 24; no. 1; pp. 134 - 143
Main Authors Cauley, Jane A, Lui, Li‐Yung, Barnes, Deborah, Ensrud, Kristine E, Zmuda, Joseph M, Hillier, Teresa A, Hochberg, Marc C, Schwartz, Ann V, Yaffe, Kristine, Cummings, Steven R, Newman, Anne B
Format Journal Article
LanguageEnglish
Published Washington, DC John Wiley and Sons and The American Society for Bone and Mineral Research (ASBMR) 01.01.2009
Wiley
Amer Soc Bone & Mineral Res
Subjects
Online AccessGet full text
ISSN0884-0431
1523-4681
1523-4681
DOI10.1359/jbmr.080813

Cover

More Information
Summary:Successful aging is multidimensional, and many phenotypes have been proposed. We examined a biomarker of aging based on repeated measures of BMD for up to 15 yr and hypothesized that maintenance of BMD will be associated with low fracture risk and disability and improved survival. We studied 9704 women recruited at four U.S. clinical centers and enrolled in the Study of Osteoporotic Fractures, a longitudinal cohort study. Of these, 8224 women had at least one hip BMD measurement. Hip BMD was measured a maximum of five times over 15 yr. Random effects regression was used to determine a BMD slope for each subject. Three groups were formed—“maintained” BMD: slope ≥0, n = 724 (9%); “expected” BMD loss: slope <0 to <1 SD below mean, n = 6478 (79%); and “accelerated” BMD loss: slope ≥1 SD below mean, n = 1022 (12%). Cox proportional hazards models were used to compare the relative hazard (RH; 95% CI) of fracture, incident mobility disability, and mortality in the maintained and accelerated groups compared with the expected. A 1 SD decrease in the BMD slope was associated with an increased risk of all outcomes. In multivariate models, the RH of nonspine fracture was 0.81 (0.71–0.93) and of hip fracture was 0.36 (0.25–0.53) for women in the maintained compared with the expected group. The incidence of mobility disability was lower in the maintained versus expected group (RH = 0.70; 95% CI = 0.59–0.83), but this was largely explained by other factors. Women who experienced accelerated bone loss were more likely to develop disability (RH = 1.56; 95% CI: 1.33–1.84). Mortality risks were lower in the maintained compared with the expected group (RH = 0.49; 95% CI: 0.42–0.58). In conclusion, a subset of older women maintained their BMD up to 15 yr, suggesting that bone loss is not an inevitable consequence of aging. These women experienced a lower risk of fractures, disability, and mortality, suggesting that this phenotype may be a marker of successful aging.
Bibliography:Dr Cauley has received research support from Merck & Company, Eli Lilly & Company, Pfizer Pharmaceuticals, and Novartis Pharmaceuticals. She has also received consulting fees from Novartis Pharmaceuticals. Dr Hochberg has received research support from the National Institutes of Health. He is a consultant for the following companies that have products related to osteoporosis and/or vertebral fractures: AMGEN, GlaxoSmithKline, Merck & Co., Novartis Pharma AG, Proctor & Gamble, Roche Laboratories, and Wyeth Pharmaceuticals. Dr Cummings receives research support from Amgen, Pfizer, Novartis, and Eli Lilly and Co. and consulting fees or honoraria from Eli Lilly and Co., Zelos, Merck and Co., Novartis, GlaxoSmithKline, Procter & Gamble, and Aventis. Drs Barnes, Ensrud, Hillier, Newman, Yaffe, and Zmuda and Ms Lui state that they have no conflicts of interest.
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0884-0431
1523-4681
1523-4681
DOI:10.1359/jbmr.080813